Actively Recruiting
Quantitative MRI for Myelofibrosis
Led by University of Michigan Rogel Cancer Center · Updated on 2025-08-17
192
Participants Needed
1
Research Sites
623 weeks
Total Duration
On this page
Sponsors
U
University of Michigan Rogel Cancer Center
Lead Sponsor
S
Sanofi
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study is for the development and validation of functional magnetic resonance imaging (MRI) parameters as biomarkers for analyzing extent of disease and quantifying response to treatment in patients with myelofibrosis.
CONDITIONS
Official Title
Quantitative MRI for Myelofibrosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female subjects over the age of 18
- Diagnosis of primary myelofibrosis, post-polycythemia vera myelofibrosis, or post-essential thrombocythemia myelofibrosis
- No contraindications to MRI
- Able to undergo MRI without anesthesia
You will not qualify if you...
- Patients with pacemakers or other implanted magnetic devices that may malfunction or move during MRI
- Any prior adverse event related to MRI not caused by contrast agents or medications
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Michigan Hospital
Ann Arbor, Michigan, United States, 48109
Actively Recruiting
Research Team
G
Gary Luker, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here